Mustbio Stock

MustBio utilizes multi-antibody technology to develop immuno-oncology therapeutics.

Sign up today and learn more about Mustbio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Mustbio Stock

MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.

Funding History

December 2022$12.5M

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: